Literature DB >> 15476175

[Molecular pharmacogenetic studies of drug responses to obsessive-compulsive disorder and six functional genes].

Lan Zhang1, Xiehe Liu, Tao Li, Yanchun Yang, Xun Hu, David Collier.   

Abstract

OBJECTIVE: To investigate the associations between the drug responses to obsessive -pulsive disorder (OCD) and six functional genes related with serotonin and dopamine.
METHODS: One hundred and thirteen OCD nuclear families were collected. The OCD patients were treated with serotonin reuptake inhibitors (SRIs) for 8 weeks and the drug responses were assessed using the Yale-Brown obsessive-compulsive scale (Y-BOCS). The patients were divided into drug responders group and non-responders group according to the reducing rate of Y-BOCS score. The genotypes of six genes were determined with the Amp-FLP and Amp-RFLP techniques and analyzed by transmission disequilibrium test (TDT). The six genes are serotonin 2A receptor (5-HT2A), serotonin transporter (5-HTT), dopamine D2 receptor ( DRD2), dopamine D4 receptor (DRD4), catechol-O- methyltransferase (COMT) and monoamine oxidase A (MAOA).
RESULTS: No association was found between the six genes and different drug responses groups. However, there was significant difference between the drug responders and non-responders in homozygosity at the 5-HT2A -1438G/A locus (chi(2)=4.69, P=0.03).
CONCLUSION: The results suggested that the 5-HT2A may play some roles in the effects of drug treatment on OCD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476175

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  6 in total

Review 1.  The genetics of obsessive-compulsive disorder and Tourette's syndrome: what are the common factors?

Authors:  Marco A Grados
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

Review 2.  Pharmacogenetics of anxiolytic drugs.

Authors:  Arun K Tiwari; Renan P Souza; Daniel J Müller
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

Review 3.  Pharmacogenetics of Obsessive-Compulsive Disorder: An Evidence-Update.

Authors:  Gwyneth Zai
Journal:  Curr Top Behav Neurosci       Date:  2021

4.  Advanced paternal age increases the risk of schizophrenia and obsessive-compulsive disorder in a Chinese Han population.

Authors:  Yuejing Wu; Xiang Liu; Hongrong Luo; Wei Deng; Gaofeng Zhao; Qiang Wang; Lan Zhang; Xiaohong Ma; Xiehe Liu; Robin A Murray; David A Collier; Tao Li
Journal:  Psychiatry Res       Date:  2012-03-16       Impact factor: 3.222

5.  Association of serotonin receptor 2a haplotypes with obsessive-compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study.

Authors:  Marzie Sina; Abolhassan Ahmadiani; Sareh Asadi; Jamal Shams
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-09       Impact factor: 2.570

6.  Response to Fluvoxamine in the Obsessive-Compulsive Disorder Patients: Bayesian Ordinal Quantile Regression.

Authors:  Samad Safiloo; Yadollah Mehrabi; Sareh Asadi; Soheila Khodakarim
Journal:  Clin Pract Epidemiol Ment Health       Date:  2021-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.